Lymphoma

Pages Tagged with "Lymphoma"

City of Hope To Accelerate Immunotherapy Research And Treatment Innovation with $15 Million Gift From Ted Schwartz Family
CONTACT Letisia Marquez (626) 476-7593lemarquez@coh.org   LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States, announced today a $15...
TV reporter Amanda Salas fought cancer in the public eye
Amanda Salas, entertainment anchor for FOX11’s Good Day L.A. morning show, was in the midst of a banner year for her career, but there were signs that something wasn’t quite...
Pivotal study led by City of Hope shows first-in-class cancer immunotherapy achieves high rate of remission in patients with a type of non-Hodgkin lymphoma
CONTACT Letisia Marquez 626-476-7593lemarquez@coh.org   Data on bispecific antibody for a non-Hodgkin lymphoma presented today at an American Society of Hematology (ASH) Annual Meeting press briefing    DUARTE, Calif...
Novel immunotherapy produces high rate of lymphoma remission
City of Hope has announced  that data from an investigational Phase 1/2, single-arm trial using a bispecific antibody called mosunetuzumab highlights the paradigm-changing potential of a new treatment option for people with...
Patients, donors meet during 45th annual BMT reunion
As a 16-year-old high school sophomore, Julian Castañeda was focused on running track — specifically, trying to run a mile in under five minutes. He was also planning to attend...
What is lymphoma, and what do you do next?
You may have heard of lymphoma or read about it in the news when actor Jeff Bridges shared his diagnosis in 2020. But did you know that lymphoma is one...
Phase 2 Trial Opens for City of Hope's Novel COVID-19 Vaccine
City of Hope is now enrolling patients in a Phase 2 clinical trial of its COH04S1 vaccine, which is the first to study the safety and effectiveness of an investigational...
First chimeric antigen receptor (CAR) T cell therapy targeting B cell-activating factor receptor (BAFF-R) eradicates blood cancers that relapsed after CD19 CAR T therapies
CONTACT Letisia Marquez 626-218-3398lemarquez@coh.org City of Hope’s research on the new CAR T, published in Science Translational Medicine, offers hope for patients who have relapsed after commercially available CD19...
Groundbreaking new therapies provide hope to blood cancer patients
For two groups of patients — older people diagnosed with acute myeloid leukemia (AML) and patients whose aggressive B cell lymphoma did not respond to treatment or had relapsed — the prognosis...
CAR T cell therapy targeting new receptor proves effective for relapsed CAR T patients
Larry Kwak, M.D., Ph.D. The first CAR T cell therapy targeting the B cell-activating factor receptor on cancerous cells eradicated CD19-targeted therapy-resistant human leukemia and lymphoma cells in animal models...